Roots Analysis

MARCH 16, 2023

The IVT mRNAs are structurally similar to natural mRNAs, these synthetic mRNAs can be used to express proteins through genetic engineering. It is worth noting that several companies have begun to develop mRNA-based cancer immunotherapies and vaccines for infectious diseases.

Vaccination 52

Vaccination Vaccine DNA Protein 52

Pharmaceutical Technology

MAY 8, 2023

Innovation S-curve for the pharmaceutical industry Zinc-finger nucleases is a key innovation area in pharmaceutical Zinc finger nucleases (ZFNs) are tools used in genetic engineering to cleave a chosen genomic sequence. The company's lead asset involving this technology is isaralgagene civaparvovec (ST 920).

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

Bioengineer

JULY 19, 2021

The development of KRAS inhibitors is, thus, an extremely active line of research. ” KRAS genes in embryonic development. The researchers at the CNIO created two genetically engineered mouse models that lacked KRAS4B and expressed the KRAS4A variant only, both with and without the G12V mutation (KRAS4AG12V).

Research 52

Research Gene Genetic Engineering Genetics 52

The Pharma Data

JANUARY 19, 2021

But altering the tracr-L with genetic engineering to make it function more like a guide RNA increased CRISPR-Cas9 cuts. At least five companies are using CRISPR-Cas9 systems to develop therapeutics: Caribou Biosciences, Intellia Therapeutics, CRISPR Therapeutics, ERS Genomics and Editas Medicine.

Bacteria 52

Bacteria Gene Editing Research RNA 52

pharmaphorum

SEPTEMBER 13, 2022

Similar to Newbury, McBean – known to be a highly respected tradesman – developed fatigue and severe pain from weak and easily broken bones. During this period, Nobel prize-winning German scientist Paul Ehrlich developed his lock-key hypothesis of molecules that specifically bind to cell receptors.

Genome Project 89

Genome Project Genome Genomics DNA 89

pharmaphorum

SEPTEMBER 4, 2020

Personalized and precision medicines are exciting fields that focus on the development of treatment and prevention strategies for a single patient or patient group. Following a ‘learning-by-doing’ approach via continuous prototyping and testing to evaluate solutions before investing time and resources on development. Holistic view.

Medicine 52

Medicine Production Genetic Engineering Genetics 52

XTalks

MARCH 28, 2024

Colorectal Cancer: Advances in Treatment Options In recent years, there has been considerable progress in understanding the biology of CRC, which has helped develop more effective and personalized treatment options. An overview of some of the most promising developments in CRC treatment is provided below.

Gene Editing 59

Gene Editing Life Science Clinical Trials Clinical Trials 59

Drug Discovery World

MARCH 13, 2023

While there is no silver bullet for increasing the availability of CGTs, improving manufacturing processes that enable their development at scale can help reduce the cost of these treatments and get them to those who need them most. But now, the increased efficiency is likely making drug development cheaper.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

The Pharma Data

SEPTEMBER 1, 2021

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. million adults in the United States.

Drugs 52

Drugs Engineer Drug Delivery Gene 52

The Pharma Data

MARCH 29, 2022

Published today in Nature, the research opens the door to developing a therapeutic spray for humans. The small molecule was developed by Drs. “Our unpublished results represent encouraging findings with the current rapid propagation of Omicron BA.2 2 around the world.” Shapira, T., Monreal, I.A.,

Genetic Engineering 52

Genetic Engineering Research Genetics Drugs 52

Drug Discovery World

JANUARY 23, 2023

Kevin Hemphill, R&D Manager at PerkinElmer’s Horizon Discovery explores how base editing has emerged as an attractive gene editing option for researchers wanting to develop stem cell-based therapies. The success of base editing has led to rapid advances toward commercialisation and clinical application.

Gene Editing 52

Gene Editing Gene Engineer DNA 52

Drug Discovery World

NOVEMBER 8, 2023

On Day 1, Tuesday 14 November 2023, the tracks include: Display of biologics, antibody-based cancer therapies, safety and efficacy of bispecific antibodies, modulating the tumour microenvironment, optimisation and developability, and cell line and systems engineering.

Antibody 64

Antibody Engineer Protein Scientist 64